Home BioMimetic Therapeutics

BioMimetic Therapeutics

acquired
IPO Delisting
Biotechnology Company

Basic Information

BioMimetic Therapeutics is a biotechnology company developing products to help stimulate the body's natural tissue regeneration processes. The company’s products and product candidates include Augment Injectable and Augment Rotator Cuff, for treating foot and ankle fusion, stimulating wrist fracture healing, surgical treatment of rotator cuff tears, and enhancing several orthopedic and sports medicine indications for tendinopathy.
BioMimetic Therapeutics, Inc.
Tennessee,United States of America
51~100 people
January 01, 1999
--